Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
NCT01756508
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
57
Enrollment
OTHER
Sponsor class
Conditions
End-Stage Renal Disease
Kidney Failure
Graft Reperfusion Injury
Interventions
DRUG:
eculizumab
Sponsor
Russian Academy of Medical Sciences